Sign up
SNN

Smith & Nephew SNATS Inc (NYSE: SNN)

Healthcare · Medical Devices

$30.32−0.19 (−0.62%)

Last close · Nov 18, 2026 · NYSE USD

Set alert

The Quantellect read. SNN fell 0.62% in the Nov 18 session to $30.32. The borrow fee is 4.32%. Four active firms cover the stock as of Nov 19, 2026; one active firm with a target averages $30.00 over 12 months. Descriptive summary of the data on this page, not a recommendation.

Relative valuation—

—

MomentumNeutral

RSI (14) 59.8 (overbought above 70, oversold below 30)

Trend—

—

Short interest0.2% of float

FINRA settlement Oct 30, 2026

SNN price chart

Price $30.32 · As of Nov 18, 2026, 3:59 PM ET

Open full chart →
Price details unavailable for this range.

Chart loads when this section enters view.

Text price and event history
6M plotted price range (ET)
Range6M
First date—
Last date—
Open—
High—
Low—
Close—
Volume—
Plotted bars0

Plotted OHLCV bars

No price bars are available for this range.

Event records

Event records load after the price chart.

Split-adjusted daily prices · Price as of —

Initial 6M price range summary
Range6M
First close—
Last close—
High—
Low—
Volume—
Open
$30.34Nov 18, 2026 session
Previous close
$30.51Nov 17, 2026 close
Day range
$30.25 – $30.72Nov 18, 2026 session
52-week range—
Volume
1.22MNov 18, 2026 session
Average volume (30 calendar days)—
Market cap—
P/E (TTM)—
Forward P/E—
EPS (TTM)—
Dividend yielddata unavailable —
Beta (5-year monthly vs SPY)—

Price history

SNN · nyse · USD

Last completed session: Nov 18, 2026

Split-adjusted · volume in shares

November 2026 · 13 completed sessions
DateOpenHighLowCloseChangeVolume
30.3430.7230.2530.32−0.19−0.622747%1,182,456
Open 30.34High 30.72Low 30.25
30.6430.8930.391830.51−0.46−1.485308%1,411,959
Open 30.64High 30.89Low 30.3918
31.4931.5930.95530.97−0.31−0.991049%1,274,747
Open 31.49High 31.59Low 30.955
31.1331.5131.042431.28+0.28+0.903226%1,365,149
Open 31.13High 31.51Low 31.0424
31.3631.5731.0031.00−0.04−0.128866%945,937
Open 31.36High 31.57Low 31.00
30.7731.1130.7131.04+0.12+0.388098%1,177,563
Open 30.77High 31.11Low 30.71
30.9331.1230.5230.92−0.13−0.41868%2,352,561
Open 30.93High 31.12Low 30.52
31.0731.1730.74531.05−0.10−0.321027%1,335,402
Open 31.07High 31.17Low 30.745
30.7331.2730.68231.15−0.86−2.68666%1,863,760
Open 30.73High 31.27Low 30.682
32.5333.0031.72532.01−0.45−1.386322%2,818,362
Open 32.53High 33.00Low 31.725
31.4332.65531.4132.46+2.29+7.590322%2,679,847
Open 31.43High 32.655Low 31.41
30.2930.38530.0530.17−0.07−0.231481%2,536,680
Open 30.29High 30.385Low 30.05
29.6630.2729.602330.24+0.54+1.818182%1,752,208
Open 29.66High 30.27Low 29.6023

Notable price movement

— · Notable price movement not available

Options flow

— · Options flow not available

Q Score

— · Q Score not available

Quantellect signals

Change since Nov 18
Squeeze27Idle—
How the scores work →

Industry comparison

— · Industry comparison not available

Upcoming events

— · Upcoming events not available

Analyst consensus

Neutral

0Strong Buy
0Buy
3Neutral
1Sell
0Strong Sell

Based on 4 active firms as of Nov 19, 2026 (365-day activity window)

12-month price targets (third-party analysts)

Low$30.00
Average$30.00
High$30.00

As of Nov 19, 2026 across 1 active firms with targets. Targets are published by third-party analysts, not by Quantellect.

Full analyst forecast →

Earnings history

— · Earnings history not available

Smart-money activity

In the last 60 days: 0 insider sales and 0 purchases. No congressional trades in 90 days.

DateTypeWhoActionAmountSource
Congress buyAlan ArmstrongBuyUnavailableCongress disclosure
Congress sellLisa C. McClainSellUnavailableCongress disclosure
Congress buyLisa C. McClainBuyUnavailableCongress disclosure
Congress sellDaniel S. GoldmanSellUnavailableCongress disclosure
Congress buyMichael T. McCaulBuyUnavailableCongress disclosure
Congress buyMichael T. McCaulBuyUnavailableCongress disclosure
Congress sellMichael T. McCaulSellUnavailableCongress disclosure
Congress buyMichael T. McCaulBuyUnavailableCongress disclosure
Congress sellMichael T. McCaulSellUnavailableCongress disclosure
Congress buyMichael T. McCaulBuyUnavailableCongress disclosure
All smart-money activity →

News and press releases

All SNN news →

Company profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization

CEO
Dr. Deepak S. Nath Ph.D.
Headquarters
Watford, United Kingdom
Employees
17,000
IPO date
Nov 16, 1999
Sector
Healthcare
Industry
Medical Devices

Data sources: exchange quotes delayed 15 minutes, FINRA short interest, SEC filings, OPRA options data and third-party analyst data. Education only. Nothing on this page is a recommendation to buy or sell a security.